Novartis Ag (NVS) Dividends Paid - Common (2009 - 2026)
Novartis Ag's (NVS) quarterly Dividends Paid - Common came in at -$2.9 billion in Q2 2026, down 15.53% year-over-year from -$3.4 billion in Q2 2025, and up 53.67% quarter-over-quarter from -$6.2 billion in Q1 2026.
Analysis
Novartis Ag (NVS) Dividends Paid - Common (2009 - 2026) Analysis & Trends
Novartis Ag has disclosed Dividends Paid - Common across 18 years of filings, most recently posting -$2.9 billion for Q2 2026.
- In Q2 2026, Dividends Paid - Common fell 15.53% year-over-year to -$2.9 billion; the TTM figure through Jun 2026 stood at -$16.9 billion (down 9.35% YoY), while the FY2025 annual figure was -$7.8 billion, down 2.54% from the prior year.
- Dividends Paid - Common came in at -$2.9 billion for Q2 2026 at Novartis Ag, up from -$6.2 billion in the prior quarter.
- In the past five years, Dividends Paid - Common ranged from a high of -$2.4 billion in Q2 2024 to a low of -$7.8 billion in Q4 2025.
- Average Dividends Paid - Common over 5 years is -$5.5 billion, with a median of -$5.8 billion recorded in 2025.
- Year-over-year, Dividends Paid - Common grew 28.23% in 2024 and retreated 16.2% in 2026.
- Over 5 years, Dividends Paid - Common stood at -$7.5 billion in 2022, then increased by 3.34% to -$7.3 billion in 2023, then fell by 5.09% to -$7.6 billion in 2024, then fell by 2.54% to -$7.8 billion in 2025, then soared by 63.28% to -$2.9 billion in 2026.
- Per Business Quant data, the three most recent Dividends Paid - Common figures were -$2.9 billion in Q2 2026, -$6.2 billion in Q1 2026, and -$7.8 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | 3.23 Bn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | 3.07 Bn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | 2.14 Bn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | -2.87 Bn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | 2.45 Bn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | 6.09 Bn |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | - |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | - |
| 10 | Neurocrine Biosciences | 15.82 Bn | 15.43 Bn | 935.80 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.87 Bn |
| Mar 31, 2026 | -6.20 Bn |
| Dec 31, 2025 | -7.82 Bn |
| Jun 30, 2025 | -2.49 Bn |
| Mar 31, 2025 | -5.33 Bn |
| Dec 31, 2024 | -7.62 Bn |
| Jun 30, 2024 | -2.42 Bn |
| Mar 31, 2024 | -5.21 Bn |
| Mar 31, 2023 | -7.26 Bn |
| Mar 31, 2022 | -7.51 Bn |
| Mar 31, 2021 | -7.37 Bn |
| Dec 31, 2020 | 13.99 Bn |
| Mar 31, 2020 | -6.99 Bn |
| Dec 31, 2019 | -6.65 Bn |
| Mar 31, 2019 | -6.65 Bn |
| Mar 31, 2018 | -6.97 Bn |
| Mar 31, 2017 | -6.50 Bn |
| Dec 31, 2016 | -6.48 Bn |
| Mar 31, 2016 | -6.48 Bn |
| Dec 31, 2015 | -6.64 Bn |